SinoMab Bioscience Ltd.
0.13
EUR
0.00
(0.00%)
Important Dates
SinoMab Bioscience Ltd.'s next confirmed earnings release is scheduled for March 22, 2027.
| Earnings Date | 3/22/2027 |
Share Statistics
As of December 31, 2024, SinoMab Bioscience Ltd. has 1.09B shares outstanding.
| Shares Outstanding | 1.09B |
Financial Position
As of December 31, 2024, SinoMab Bioscience Ltd. maintains a current ratio of 0.91, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.91 |
| Quick Ratio | 0.53 |
| Debt / Equity | 250.00 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2024.
| Employee Count | 155.00 |
Stock Price Statistics
EURThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 0.13 |
Balance Sheet
EURAs of December 31, 2024, SinoMab Bioscience Ltd. holds 14.14M in cash and equivalents against 63.81M in total debt, resulting in a net debt position of 47.29M. Total book value stands at 25.52M, with working capital of -2.40M providing operational flexibility.
| Cash & Cash Equivalents | 14.14M |
| Total Debt | 63.81M |
| Net Debt | 47.29M |
| Equity (Book Value) | 25.52M |
| Book Value Per Share | 0.02 |
| Working Capital | -2.40M |